Navigation Links
Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
Date:1/23/2009

f="http://www.cordexpharma.com/index2_files/investor.htm" target="_new">http://www.cordexpharma.com/index2_files/investor.htm. Registration for the webcast begins at 11:30 a.m. EST on Thursday, January 29. Please check in at least 5 minutes before the scheduled start time at 12:00 p.m. EST to allow for a short registration process. The webcast will be archived for at least 14 days following the presentation.

"We are pleased to have Dr. Stamler present his group's cutting-edge cardiovascular research at Duke University and the nitric oxide/redox imbalance in heart failure as a novel target for drug development," said Dr. Kuo, chief executive officer of Cordex. "While there are several available therapies for heart failure, Cordex's investigational drugs, which are based on proprietary technology developed by Dr. Stamler, are designed to restore nitric oxide/redox balance in the failing heart and improve excitation-contraction coupling and cardiac pumping efficiency."

Dr. Stamler completed his undergraduate studies at Brandeis University, earned his M.D. from Mount Sinai School of Medicine in New York City and completed his medical residency and fellowship training in both cardiology and pulmonary medicine at Harvard Medical School and the Brigham and Women's Hospital. Dr. Stamler joined the faculty of Harvard Medical School as Assistant Professor of Medicine in October 1993. In December 1993, he joined the faculty of Duke University as an Associate Professor of Medicine, and in 1996, was promoted to full Professor.

Dr. Stamler's work has centered on elucidating the fundamental physiological regulatory roles of nitric oxide mediated by S-nitrosylation, a ubiquitous protein modification. The ramifications of his work extend to all major classes of proteins: ion channels, receptors, G proteins, transcription factors, membrane trafficking proteins and num
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Axikin Pharmaceuticals Spins out of Actimis
2. Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
3. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
4. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
5. Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
6. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
7. Cumberland Pharmaceuticals Appoints Lee Product Director
8. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
9. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
10. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Array BioPharma Inc. (NASDAQ: ARRY ... agreement with Novartis Pharma AG to acquire worldwide rights ... 3 development.  This agreement is conditional on the closing of ... 22, 2014, which are expected to close in the ...
(Date:1/22/2015)... BOSTON , Jan. 22, 2015  Transwestern | RBJ today ... feet of office space for Shire a leading biopharmaceutical company, ... . Transwestern | RBJ,s Robert Richards , president, and ... the lease for the entire five-floor building at 95 Hayden ...
(Date:1/22/2015)... laboratory information management systems market is a rapidly growing ... due to factors such as rising pressure to comply ... and increasing government support for adoption of HCIT solutions ... the market focus on technological advancements to further the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 zFlo Motion ... pleased to announce an exciting product from a new partner. ... analysis solutions over the past 15 years, with offerings in ... recently, their 3D IMU system (inertial measurement unit), iSen, is ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2
... for the First Three Months of 2008., COPENHAGEN, May ... three month period ended March 31, 2008.,During this period, Genmab ... million (approx. USD 36 million) for the,first quarter of 2008. ... 80 million (approx. USD 17 million)., An operating loss ...
... SoluLinK, Inc., a leader in,next-generation conjugation products ... of a new product, NanoLink(TM) Streptavidin Magnetic,Microspheres. ... of any commercially available polymer-encapsulated streptavidin,magnetic microsphere. ... throughput robotic applications where high biotin loads,must ...
... 28 The automation of,transaction-based processing is ... the United States. Foresight Corporation of Dublin, ... scale of installations of Transaction,Insight(R) - the ... Transaction automation techniques enable healthcare organizations to,cut ...
Cached Biology Technology:Genmab Announces 2008 First Quarter Results 2Genmab Announces 2008 First Quarter Results 3Genmab Announces 2008 First Quarter Results 4SoluLinK Introduces NanoLink(TM) Streptavidin Magnetic Microspheres 2New Trend Sweeping Nation's Health Plans: Transaction Automation 2
(Date:1/22/2015)... , January 22, 2015 , ... tenth year  The European Patent Office to present a ... Two British nominations to be featured: Christofer Toumazou and ... featuring former finalists and winners of the Award   ...
(Date:12/22/2014)... 2014  NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... the growing mobile commerce market, announces it has retained famous ... the 2015 International CES debut of the Wocket™ biometric smart ... at the NXT-ID booth January 6th and 7 th , ...
(Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014  23andMe, Inc., ... a study that pinpoints fine-scale differences in genetic ancestry of ... Since immigrants first arrived more than four hundred ... served as a meeting place for peoples from different continents. ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... mutations in BRCA1 and BRCA2 genes have a significantly higher ... risk have been seeking genetic testing and counseling based on ... sequencing is labor-intensive, costly, and it only targets a part ... Canadian scientists has developed a new sequencing approach to provide ...
... emerged centuries ago in Europe has now been ... industrialization. Unlike other diarrheal diseases, this one is ... clean water. As developing countries become more industrialized ... flexneri are known to decline, associated with ...
... (DOE) announced Aug. 2 that a team of engineers ... million to design a battery management system for lithium-ion ... This is a particularly challenging project because the electrochemical ... mathematical form. The project is one of 12 ...
Cached Biology News:New method provides fast, accurate, low cost analysis of BRCA gene mutations in breast cancer 2Out of Europe 2Out of Europe 3$3.2 million to develop battery management system for electric-car batteries 2$3.2 million to develop battery management system for electric-car batteries 3$3.2 million to develop battery management system for electric-car batteries 4
Human sIL-2R/CD25 ELI-PAIR Kit...
Request Info...
ANTI-HUMAN CYTOKINES, GROWTH FACTORS (polyclonal rabbit (or goat) antibodies) Human TARC - Biotin...
Anti-Bcl-G (CT) Host: rabbit polyclonal Species Reactivity: human, mouse, rat Applications: WB, IHC Storage: 4C...
Biology Products: